arrow
S

Su-Jin Shin

yonsei university college of medicine
H指数:31
被引数:3,238

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Deep learning-based mitotic quantification for objective adjunct for grading of urothelial carcinoma: a multi-institutional validation study

基于深度学习的有丝分裂量化作为尿路上皮癌分级客观辅助手段:一项多中心验证研究

2026-10-220
OAAI
A phase II clinical trial of paclitaxel-carboplatin as neoadjuvant therapy followed by surgery in patients with locally advanced head and neck squamous cell carcinoma

一项将紫杉醇-卡铂作为新辅助治疗,随后进行手术的II期临床试验,针对局部晚期头颈部鳞状细胞癌患者

2025-10-110
PRE
Proportion of histologic component predicts lymph node metastasis risk in undifferentiated-type mucosal and submucosal gastric cancers

未分化型黏膜及黏膜下胃癌中,组织学成分比例可预测淋巴结转移风险。

2025-08-090
PRE
Avelumab plus sacituzumab govitecan versus avelumab monotherapy as first-line maintenance treatment in patients with advanced urothelial carcinoma: JAVELIN Bladder Medley interim analysis☆

阿维鲁姆单抗联合沙西妥珠单抗戈维他胺与阿维鲁姆单抗单药治疗作为晚期尿路上皮癌患者的一线维持治疗方案:JAVELIN Bladder Medley研究中期分析☆

2025-06-010
OAAI
Revealing 3D microanatomical structures of unlabeled thick cancer tissues using holotomography and virtual H&E staining

Park J, Shin SJ, Kim G, Cho H, Ryu D, Ahn D, et al. 利用全息断层扫描和虚拟H&E染色揭示未标记厚癌组织的3D微解剖结构。Nat Commun. (2025) 16:4781. doi: 10.1038/s41467-025-59820-0

2025-05-220
OAAI
Enfortumab vedotin plus pembrolizumab (EV plus P) vs chemotherapy (Chemo) in previously untreated locally advanced or metastatic urothelial carcinoma (la/mUC): Pan-Asian subgroup analysis from EV-302/KEYNOTE-A39

恩夫妥木单抗联合帕博利珠单抗(EV联合P)对比化疗(Chemo)在既往未治疗的局部晚期或转移性尿路上皮癌(la/mUC)中的疗效:EV-302/KEYNOTE-A39的泛亚洲亚组分析

2024-12-010
PRE
Histopathologic image-based deep learning classifier for predicting platinum-based treatment responses in high-grade serous ovarian cancer

基于组织病理学图像的深度学习分类器预测高级别浆液性卵巢癌的铂类治疗反应

2024-05-183
OAAI